Can topical lidocaine be used to treat erythromelalgia?

Topical Lidocaine for Erythromelalgia

Yes, topical lidocaine is an effective first-line treatment option for erythromelalgia pain, with lidocaine patches (5% prescription or 4% OTC) being superior to creams or gels due to sustained delivery over 12-24 hours. 1

Mechanism and Formulations

Lidocaine blocks sodium ion channels required for neuronal impulse initiation and conduction, providing local anesthesia when applied topically to affected areas (feet, hands, or other sites). 1 The medication is available in three formulations:

• Lidocaine 5% patches (prescription) - Most effective formulation 1
• Lidocaine 4% patches (OTC) - Available without prescription 1
• Lidocaine cream or gel - Less effective than patches 1

Clinical Evidence and Efficacy

Patches demonstrate superior efficacy compared to gel formulations. In a case series of 34 patients with erythromelalgia, most patients using lidocaine 5% patches reported pain improvement, whereas 10 previous patients failed to respond to lidocaine gel. 1 The patches deliver lidocaine gradually over hours, explaining their enhanced effectiveness. 1

Important Caveats:

• Patients with more severe and longer-duration disease tend to respond less favorably to lidocaine patches 1
• All patients in the case series had tried multiple treatments before lidocaine patches, suggesting it may work better earlier in the disease course 1
• No systemic absorption or lidocaine toxicity was observed in clinical use 1

Practical Application

Apply up to 3 lidocaine patches to the dorsal or plantar surfaces of feet for 12-24 hours. 1 Patches are particularly practical for foot involvement and can be applied to hands or other affected areas as needed. 1

Trial duration: Allow at least 4 weeks before switching to alternative topical treatments. 1

Position in Treatment Algorithm

According to Mayo Clinic guidelines, topical treatments including lidocaine are first-line pharmacologic therapy for erythromelalgia, preferred over systemic medications due to fewer adverse effects. 1 Topical therapy addresses pain directly, while other topicals (like compounded midodrine 0.2%) target redness. 1

Treatment Hierarchy:

1. First-line: Topical lidocaine patches (along with other topical options) 1
2. Second-line: Systemic aspirin 325 mg daily 1
3. Third-line: Gabapentin/pregabalin or other systemic agents 1

Alternative and Combination Approaches

If lidocaine patches alone prove insufficient, consider:

• Compounded amitriptyline 1-2% with ketamine 0.5% - 75% of patients showed improvement in one case series 1
• Multi-ingredient compounded formulations adding clonidine, gabapentin, and/or lidocaine to amitriptyline-ketamine base 1

Topical lidocaine was the most commonly prescribed treatment in a pediatric erythromelalgia cohort (44% of patients), though disease course remained variable. 2

Special Considerations

Lidocaine sensitivity varies by mutation status. Patients with sodium channel mutations (NaV 1.7,1.8, or 1.9) showed increased lidocaine sensitivity for supra-threshold heat stimuli, particularly those with the NaV 1.7 I848T mutation. 3 However, this differential sensitivity did not translate to consistently superior clinical outcomes across all erythromelalgia patients. 3

For systemic treatment when topical therapy fails, sodium channel blockers like mexiletine or intravenous lidocaine infusions may be considered, particularly in primary inherited erythromelalgia. 4